177 related articles for article (PubMed ID: 23271773)
1. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
Hoffman RM
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
[TBL] [Abstract][Full Text] [Related]
2. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
Donovan JL
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
[TBL] [Abstract][Full Text] [Related]
3. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Stewart ST; Bhatnagar V; Sweeney CJ; Stahl JE; McMahon PM
JAMA; 2010 Dec; 304(21):2373-80. PubMed ID: 21119084
[TBL] [Abstract][Full Text] [Related]
5. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
[TBL] [Abstract][Full Text] [Related]
6. Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.
Hall IJ; Lee Smith J
Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S483-8. PubMed ID: 26590643
[TBL] [Abstract][Full Text] [Related]
7. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
Wilt TJ
Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in men undergoing active surveillance for localized prostate cancer.
Bergman J; Litwin MS
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780
[TBL] [Abstract][Full Text] [Related]
9. Patient decision aids for prostate cancer treatment: a systematic review of the literature.
Lin GA; Aaronson DS; Knight SJ; Carroll PR; Dudley RA
CA Cancer J Clin; 2009; 59(6):379-90. PubMed ID: 19841280
[TBL] [Abstract][Full Text] [Related]
10. Patient and family communication during consultation visits: The effects of a decision aid for treatment decision-making for localized prostate cancer.
Song L; Tyler C; Clayton MF; Rodgiriguez-Rassi E; Hill L; Bai J; Pruthi R; Bailey DE
Patient Educ Couns; 2017 Feb; 100(2):267-275. PubMed ID: 27692491
[TBL] [Abstract][Full Text] [Related]
11. Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.
Hamilton AS; Wu XC; Lipscomb J; Fleming ST; Lo M; Wang D; Goodman M; Ho A; Owen JB; Rao C; German RR
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):213-20. PubMed ID: 23271776
[TBL] [Abstract][Full Text] [Related]
12. Decision aids for people facing health treatment or screening decisions.
Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Decision Aids for Newly Diagnosed Patients with Prostate Cancer Making Treatment Decisions.
Adsul P; Wray R; Spradling K; Darwish O; Weaver N; Siddiqui S
J Urol; 2015 Nov; 194(5):1247-52. PubMed ID: 26055824
[TBL] [Abstract][Full Text] [Related]
14. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based patient choice: a prostate cancer decision aid in plain language.
Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
[TBL] [Abstract][Full Text] [Related]
16. A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial.
Chabrera C; Zabalegui A; Bonet M; Caro M; Areal J; González JR; Font A
Cancer Nurs; 2015; 38(3):E42-50. PubMed ID: 25010250
[TBL] [Abstract][Full Text] [Related]
17. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
Chabrera C; Font A; Caro M; Areal J; Zabalegui A
Cancer Nurs; 2015; 38(1):E55-60. PubMed ID: 24831045
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing patients' acceptance and adherence to active surveillance.
Penson DF
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):207-12. PubMed ID: 23271775
[TBL] [Abstract][Full Text] [Related]
19. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
[TBL] [Abstract][Full Text] [Related]
20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
